The Discounted Cash Flow (DCF) valuation of Intercept Pharmaceuticals Inc (ICPT) is (141.69) USD. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on DCF is -845.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.8% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (334.72) - (92.47) | (141.69) |
| Upside | -1861.7% - -586.7% | -845.7% |